🇺🇸 VCEL — Vericel Corporation

Salud Compra fuerte
← Volver

Precio actual

45,48 USD

Máx. histórico

1.410,00

10633 días

Split 1:20 del 16/10/2013

Caída desde máximo

-96,77%

Rango 52 semanas

28,95 – 49,32

Variación hoy

+10,68%

Cierre anterior

41,09

Rango de hoy

42,07 – 45,98

Volumen hoy

1.742.273

Peor caída histórica

-99,88%

24/09/1997 → 17/11/2015

Aún sin recuperar

Volatilidad anualizada ⓘ

97,58%

Información
Nombre completo
Vericel Corporation
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
398
PER ⓘ
96,77 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
59,71 USD (puede no estar actualizado)
Primera cotización
04/02/1997
Precio actualizado
hace 8 horas
Sobre la empresa

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies and specialty biologic products for sports medicine and severe burn care markets in North America. The company markets autologous cell therapy products comprising MACI, an autologous cultured chondrocytes on porcine collagen membrane for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns; and NexoBrid, a biological orphan product for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness thermal burns. Vericel Corporation was formerly known as Aastrom Biosciences, Inc. and changed its name to Vericel Corporation in November 2014. The company was incorporated in 1989 and is headquartered in Burlington, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
16/10/2013 1:20
18/02/2010 1:8
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/02/2011 52,60 59,20 52,40 57,20 +9,16% 12,93% 128.405
03/02/2011 52,80 53,00 51,40 52,40 -0,76% 3,03% 24.345
02/02/2011 52,80 53,20 52,00 52,80 +0,38% 2,27% 20.710
01/02/2011 53,20 53,60 52,20 52,60 -1,13% 2,63% 20.555
31/01/2011 52,40 54,00 52,00 53,20 +1,53% 3,82% 31.495
28/01/2011 53,20 53,80 52,20 52,40 -1,50% 3,01% 30.855
27/01/2011 54,40 54,80 53,00 53,20 -3,62% 3,31% 42.350
26/01/2011 57,20 57,20 54,60 55,20 -1,78% 4,55% 47.300
25/01/2011 53,40 57,40 53,00 56,20 +6,44% 8,24% 113.260
24/01/2011 53,00 53,80 52,00 52,80 +0,76% 3,40% 36.315
21/01/2011 53,60 54,20 51,80 52,40 -0,76% 4,48% 70.195
20/01/2011 59,00 59,00 51,20 52,80 -9,28% 13,22% 175.150
19/01/2011 61,00 61,00 57,80 58,20 -4,28% 5,25% 95.625
18/01/2011 64,00 64,00 59,40 60,80 -1,30% 7,19% 127.240
14/01/2011 62,60 63,40 60,00 61,60 -1,60% 5,43% 120.850
13/01/2011 64,00 65,00 61,60 62,60 +0,64% 5,31% 148.965
12/01/2011 60,00 64,40 59,60 62,20 +5,07% 8,00% 175.380
11/01/2011 65,00 65,20 58,00 59,20 -8,92% 11,08% 310.255
10/01/2011 53,80 65,60 53,00 65,00 +25,00% 23,42% 517.795
07/01/2011 53,60 53,60 52,00 52,00 +0,39% 2,99% 68.630
06/01/2011 52,80 53,20 51,80 51,80 -2,26% 2,65% 51.525
05/01/2011 52,40 53,20 51,60 53,00 +1,15% 3,05% 52.205
04/01/2011 54,00 54,00 51,60 52,40 -2,24% 4,44% 65.295
03/01/2011 51,60 54,60 51,60 53,60 +4,69% 5,81% 84.575
31/12/2010 51,20 53,40 50,00 51,20 +0,00% 6,64% 77.525
30/12/2010 55,00 55,20 50,20 51,20 -4,83% 9,09% 106.315
29/12/2010 56,80 58,80 52,00 53,80 -1,82% 11,97% 169.035
28/12/2010 47,00 55,40 47,00 54,80 +16,60% 17,87% 311.455
27/12/2010 46,00 47,40 45,20 47,00 +3,98% 4,78% 68.720
23/12/2010 45,80 46,20 45,00 45,20 -1,74% 2,62% 54.145